This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Windows on the Brain: Formation and Function of Synapses and Circuits and their Disruption in Disease
Organizer(s): Kristin Scott, Paola Arlotta, Rui M. Costa and Yimin Zou
Date: January 21 - 25, 2019
Location: Sagebrush Inn & Suites, Taos, NM, USA
Sponsored by Takeda Pharmaceutical Company Limited
Summary of Meeting:
A fundamental goal of neuroscience is to understand the molecular, cellular and activity-based mechanisms that control the formation and function of neural circuits and determine how these mechanisms become compromised in neurodevelopmental, psychiatric and neurodegenerative disorders. Over the past two decades, molecular neuroscientists have identified key molecules and mechanisms that underlie synapse development, activity and stability. Meanwhile, the study of neuronal circuits has been revolutionized by new methods to visualize and map circuits in living animals, as well as the development of approaches to control neuronal activity. Finally, disease researchers have identified genes associated with neurodevelopmental and psychiatric disorders and neurodegenerative diseases. Animal models of these diseases are proving useful to understand how dysfunction of affected genes and proteins contributes to disease pathology. Although these fields are working on the same process, no small highly interactive “Keystone Symposia-style” meeting brings these three groups together in the same room. This symposium will bring together leaders working on synapse development and function, circuit structure and function, and the study of brain disease, believing with confidence that mutually beneficial insights will emerge from discussing each other’s work.
Scholarship Deadline: October 17 2018
Discounted Abstract Deadline: October 17 2018
Abstract Deadline: October 25 2018
Discounted Registration Deadline: November 28 2018
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Biogen

Circuit Therapeutics
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1 R13 NS108719-01
Funding for this conference was made possible (in part) by 1 R13 NS108719-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found